Nasdaq:US$15.01 (+0.18) | HKEX:HK$23.70 (+0.32) | AIM:£2.18 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 26 Apr 2025

Targeting KEAP1/NRF2 signaling sensitizes KRAS-driven NSCLC to KRAS inhibitors